Melis Pehlivantürk Kızılkan1, Sinem Akgül1, Filiz Akbıyık2, Orhan Derman1, Nuray Kanbur1. 1. Department of Pediatrics, Division of Adolescent Medicine, Hacettepe University Ihsan Dogramaci Children's Hospital, Ankara, Turkey, Ankara, Turkey. 2. Department of Medical Biochemistry, Hacettepe University Hospital, Ankara, Turkey.
Abstract
BACKGROUND: Since vitamin D has an inhibitory function on ductal morphogenesis of the pubertal mammary gland, it may have a role in the development of gynecomastia. The aim of this study was to determine the effect of vitamin D deficiency on the development of pubertal gynecomastia. METHODS: Serum 25-hydroxyvitamin D (25D) levels in 50 adolescents with pubertal gynecomastia and 54 healthy controls between the ages of 11 and 17 years were compared. RESULTS: Mean 25D level was 14.03 ± 6.38 (5.0-32.5) ng/ml in the pubertal gynecomastia group and 15.19 ± 6.49 (5.0-33.2) ng/ml in the control group (p = 0.361). According to the vitamin D status classification of the American Academy of Pediatrics, 66% of the pubertal gynecomastia group was found to be deficient and 14% were insufficient. In the control group these values were 53.7% and 29.6%, respectively (p = 0.158). CONCLUSION: From our results we hypothesize that, rather than low serum levels of 25D, a dysregulation of the vitamin D signal pathway, vitamin D metabolism or vitamin D storage within the mammary tissue might be the contributing factors to the development of gynecomastia.
BACKGROUND: Since vitamin D has an inhibitory function on ductal morphogenesis of the pubertal mammary gland, it may have a role in the development of gynecomastia. The aim of this study was to determine the effect of vitamin D deficiency on the development of pubertal gynecomastia. METHODS: Serum 25-hydroxyvitamin D (25D) levels in 50 adolescents with pubertal gynecomastia and 54 healthy controls between the ages of 11 and 17 years were compared. RESULTS: Mean 25D level was 14.03 ± 6.38 (5.0-32.5) ng/ml in the pubertal gynecomastia group and 15.19 ± 6.49 (5.0-33.2) ng/ml in the control group (p = 0.361). According to the vitamin D status classification of the American Academy of Pediatrics, 66% of the pubertal gynecomastia group was found to be deficient and 14% were insufficient. In the control group these values were 53.7% and 29.6%, respectively (p = 0.158). CONCLUSION: From our results we hypothesize that, rather than low serum levels of 25D, a dysregulation of the vitamin D signal pathway, vitamin D metabolism or vitamin D storage within the mammary tissue might be the contributing factors to the development of gynecomastia.
Entities:
Keywords:
25-Hydroxyvitamin D; Pubertal gynecomastia; Vitamin D deficiency
Authors: R R Buras; L M Schumaker; F Davoodi; R V Brenner; M Shabahang; R J Nauta; S R Evans Journal: Breast Cancer Res Treat Date: 1994 Impact factor: 4.872
Authors: Kotha Subbaramaiah; Patrick G Morris; Xi Kathy Zhou; Monica Morrow; Baoheng Du; Dilip Giri; Levy Kopelovich; Clifford A Hudis; Andrew J Dannenberg Journal: Cancer Discov Date: 2012-01-27 Impact factor: 39.397
Authors: Cintia Milani; Maria Lucia Hirata Katayama; Eduardo Carneiro de Lyra; JoEllen Welsh; Laura Tojeiro Campos; M Mitzi Brentani; Maria do Socorro Maciel; Rosimeire Aparecida Roela; Paulo Roberto del Valle; João Carlos Guedes Sampaio Góes; Suely Nonogaki; Rodrigo Esaki Tamura; Maria Aparecida Azevedo Koike Folgueira Journal: BMC Cancer Date: 2013-03-15 Impact factor: 4.430